Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Cyproterone Acetate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,814Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EMA committee recommends restriction in use of cyproterone
    EMA committee recommends restriction in use of cyproterone

    31 Mar 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=122067&sid=2

    PHARMABIZ
    31 Mar 2020
    Share Share
    Restrictions in use of cyproterone due to meningioma risk
    Restrictions in use of cyproterone due to meningioma risk

    28 Mar 2020

    // EMA

    https://www.ema.europa.eu/en/news/restrictions-use-cyproterone-due-meningioma-risk-0

    EMA
    28 Mar 2020
    Share Share
    Restrictions in use of cyproterone due to meningioma risk
    Restrictions in use of cyproterone due to meningioma risk

    14 Feb 2020

    // EMA

    https://www.ema.europa.eu/en/news/restrictions-use-cyproterone-due-meningioma-risk

    EMA
    14 Feb 2020
    Share Share